19th IMS Annual Meeting
AUGUST 25-27, 2022 | LOS ANGELES, CALIFORNIA
Join me at the 19th International Myeloma Society Annual Meeting!
I'm excited to speak at the 19th IMS Annual Meeting in Los Angeles, California!
Relapsed MM, Unmet needs and future questions
About S. Vincent Rajkumar:
S. Vincent Rajkumar, M.D., is the Editor in Chief of Blood Cancer Journal, and the Edward W. and Betty Knight Scripps Professor of Medicine, Mayo Clinic, Rochester, Minnesota. His academic career was profiled by The Lancet: Nov 26th 2011 issue. His scientific contributions include clinical trials, epidemiological studies, and laboratory research focused on myeloma and related disorders. He has led multiple clinical trials including the pivotal trial that led to the approval of thalidomide for the treatment of multiple myeloma in the United States. He has also led several large studies on the prevalence and progression of monoclonal gammopathies, racial disparities in the incidence of myeloma, and familial predisposition. Dr. Rajkumar has identified several biomarkers that are used in the diagnosis and risk stratification of plasma cell disorders. He is co-chair of the International Myeloma Working Group (IMWG), and Chair of the Eastern Cooperative Oncology Group (ECOG) myeloma committee. He also serves as the Associate Editor for: Mayo Clinic Proceedings, Leukemia, and European Journal of Hematology. Dr. Rajkumar has received several awards including the Giants of Cancer Care Award (2019) from OncLive, the Robert A. Kyle Lifetime Achievement Award from by International Myeloma Foundation (IMF), and the Jan Waldenstrom Lifetime Achievement Award from the International Myeloma Society (IMS). He was named Mayo Clinic Distinguished Investigator in 2018. He serves on the board of directors for the International Myeloma Foundation and is a member of the National Institutes of Health’s Multiple Myeloma Steering Committee. Dr. Rajkumar has over 700 publications, including over 400 peer-reviewed original research papers, and over 200 reviews and book chapters.
About Our Meeting
The International Myeloma Society Annual Meeting is the defining meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects, including:
- Scientific Programs
- Keynote Addresses
- Poster Presentations
- Oral Presentations (Basic Biology, Preclinical Trials and Clinical Studies)
Testimonials
“I’ve already come away with so many great ideas from the interactions and discussions here in Vienna. You just can’t get that any other way. It's what’s been missing for the past 2 years!”
STEVEN P. TREON, MD, PhD, FACP, FRCP
Dana Farber Cancer Institute
Boston, MA
“The 18th International Myeloma Workshop in Vienna. A milestone. Immunotherapies definitely revolutionize the treatment and challenge autologous transplantation. A very special congress I will always remember.”
LAURENT GARDERET, MD, PhD
Sorbonne Université, APHP
Paris, France
Join Us in Los Angeles
